Abstract
Background
During the second wave of COVID-19 pandemic, there was surge in reporting of COVID-19-associated mucormycosis cases. Government of India declared rhino-orbito-cerebral mucormycosis as a notifiable disease. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs and aggressive surgical debridement. Even though prosthetic rehabilitation with zygomatic implants is one of the most conservative and effective options, owing to unpredictability of disease prognosis and financial burden for patients, rehabilitation with interim obturators is beneficial for patients. Hence, the current study aimed to evaluate the impact of interim obturators on quality of life (QOL) of COVID-19-associated mucormycosis patients post-maxillectomies.
Methods
The study compromised 41 subjects who underwent maxillectomies for COVID-19-associated mucormycosis and prosthetically rehabilitated with interim obturator on the 5th postoperative day. Out of 41, four deaths were reported. The subjects were classified into six classes based on Armany’s classification of post-surgical maxillectomy defects. They were followed up for a period of 6 months, and QOL was assessed using Obturator Functioning Scale.
Results
Significant association between the type of maxillectomy and QOL was detected with a p-value of 0.002. Retention of the obturator has a highly significant association with QOL (p < 0.001). Stability, ability to eat and speech also demonstrated significant correlation with QOL showing p-value of 0.022, 0.04 and 0.001, respectively. This study revealed no significant association between QOL and various classes of Armany’s classification of post-surgical maxillectomy defects.
Conclusion
This study demonstrated interim obturator significantly improved the quality of life (QOL) among the COVID-19-associated mucormycosis patients who underwent maxillectomies.
Similar content being viewed by others
References
Ravi MB, Srinivas S, Silina E, Sengupta S, Tekwani T, Achar RR (2022) Prosthetic rehabilitation of rhino orbital mucormycosis associated with COVID-19: a case series. Clin CosmetInvestig Dent 14:1–10
Singh AK, Singh R, Joshi SR, Misra A (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 15(4):102146. https://doi.org/10.1016/j.dsx.2021.05.019
Rao VUS, Arakeri G, Madikeri G, Shah A, Oeppen RS, Brennan PA (2021) COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Br J Oral Maxillofac Surg 59(9):1095–1098. https://doi.org/10.1016/j.bjoms.2021.06.013
Ray I, Bardhan M, Hasan MM, Sahito AM, Khan E, Patel S, Jani I, Bhatt PK, Sp R, Swed S (2022) Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic. Ann Med Surg (Lond) 78:103797
Jeong W et al (2019) The epidemiology and clinical manifestations of mucormycosis: a systematic review and metaanalysis of case reports. Clin Microbiol Infect 25:26–34
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, Rabaan AA, Al-Omari A, Tirupathi R, AlQahtani M, AlBahrani S, Dhama K (2021) COVID-19 and mucormycosis superinfection: the perfect storm. Infection 49(5):833–853. https://doi.org/10.1007/s15010-021-01670-1
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B et al (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis 19(12):e405–e421
Patel N, Mel A, Patel P, Fakkhruddin A, Gupta S (2023) A novel method to rehabilitate post-mucormycosis maxillectomy defect by using patient-specific zygoma implant. J Maxillofac Oral Surg 22(Suppl 1):118–123. https://doi.org/10.1007/s12663-023-01847-1
GuptaAakarshan VA, IslamJahnurIkramul AS (2016) Maxillofacial defects and their classification: a Review. Int J Adv Res 4:109–114
Soofi ZI, Yazdanie N, Kazmi SM (2015) Innovative two-part impression technique for an extensive maxillary defect. J Coll Physicians Surg Pak 25(10):765767–766693. https://doi.org/10.2015/JCPSP.765767
Tryde G, Olsson K, Jensen SA, Cantor R, Tarsetano JJ, Brill N (1965) Dynamic impression methods. J Prosthet Dent 15(6):1023–1034. https://doi.org/10.1016/0022-3913(65)90179-4
Tandon A, Pandey L (2021) COVID-19, steroids, and mucormycosis: What an ophthalmologist should know. Indian J Ophthalmol 69(7):1970
AngleenaY D, Vinod B (2015) Prosthetic rehabilitation of the dentate maxillectomy patient from a delayed surgical to an interim obturator: A clinical case report. CHRISMED J Health Res 2(1):68. https://doi.org/10.4103/2348-3334.149351
Riaz N, Warriach RA (2010) Quality of life in patients with obturator prostheses. J Ayub Med Coll Abbottabad 22(2):121–125
Ali MM, Khalifa N, Alhajj MN (2018) Quality of life and problems associated with obturators of patients with maxillectomies. Head Face Med 14(1):2. https://doi.org/10.1186/s13005-017-0160-2.PMID:29329558;PMCID:PMC5795281
Andrades P, Militsakh O, Hanasono MM, Rieger J, Rosenthal EL (2011) Current strategies in reconstruction of maxillectomy defects. Arch Otolaryngol Head Neck Surg 137(8):806–812. https://doi.org/10.1001/archoto.2011.132.PMID:21844415;PMCID:PMC3951334
Irish J, Sandhu N, Simpson C, Wood R, Gilbert R, Gullane P, Barker E (2019) Quality of life in patients with maxillectomy prostheses. Head Neck 31(6):813–821. https://doi.org/10.1002/hed.21042
Kumar P, Alvi HA, Rao J, Singh BP, Jurel SK, Kumar L, Aggarwal H (2013) Assessment of the quality of life in maxillectomy patients: A longitudinal study. J Adv Prosthodont 5(1):29–35. https://doi.org/10.4047/jap.2013.5.1.29
Radhika C et al (2013) Quality of life after maxillectomy and prosthetic obturator rehabilitation. J Oral Maxillofac Surg 71(8):1471–1478
Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O (2003) Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 51:231–236
Keyf F (2001) Obturator prostheses for hemimaxillectomy patients. J Oral Rehabil 28(9):821–829. https://doi.org/10.1046/j.1365-2842.2001.00754.x
Acknowledgements
We greatly acknowledge the contribution of faculty from the Departments of ENT, Radiology, General Medicine, Clinical Virology, General Pathology and Microbiology, SVIMS, who helped in establishing diagnosis and rendered treatment for COVID-19-associated mucormycosis patients of this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chittamuru, N.R., Vengamma, B., Priya, P.V. et al. An Observational Study on Impact of Interim Obturators in COVID-19-Associated Mucormycosis. J. Maxillofac. Oral Surg. (2024). https://doi.org/10.1007/s12663-024-02120-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12663-024-02120-9